Tailored tumor testing aims to match kids with best brain cancer therapy
NCT ID NCT05057702
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study is testing a new approach for children and young adults whose medulloblastoma or ependymoma has come back. Researchers will analyze each person's tumor using drug screening and genetic testing to create a personalized treatment plan. The goal is to find the most effective and least toxic therapies for each participant, and to see if this personalized approach is feasible within a few weeks after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPENDYMOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Los Angeles
RECRUITINGLos Angeles, California, 90027, United States
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Children's Minnesota
RECRUITINGMinneapolis, Minnesota, 55404, United States
-
Children's National Hospital
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
New York University
RECRUITINGNew York, New York, 10016, United States
-
Rady Children's Hospital
RECRUITINGSan Diego, California, 92123, United States
-
St. Louis Children's Hospital / Washington University in St. Louis
RECRUITINGSt Louis, Missouri, 63130, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can the Body's own immune cells beat a recurrent brain tumor?
- Can AI read tumor slides to outsmart childhood cancer?
- Could an antiparasitic drug boost radiation against childhood brain tumors?
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?